@pittcp3.bsky.social
Center for Pharmaceutical Policy and Prescribing at the University of Pittsburgh. Our research helps improve quality, safety, & efficiency of medication use.
🆕editorial in @jamainternalmed.com by CP3’s @timandersonmd.bsky.social & colleagues examines when statins should be used for prevention of ASCVD. As risk calculators evolve, debate continues over lowering treatment thresholds.
jamanetwork.com/journals/jam...
In @jamainternalmed.com, CP3's @timandersonmd.bsky.social & coauthors describe strategies for medication safety for older adults in the emergency department.
jamanetwork.com/journals/jam...
New @cidrap.bsky.social article offers tips to avoid inappropriate dental antibiotic use to curb resistance and patient harm. CP3’s Katie Suda was interviewed, highlighting stewardship strategies for dentists to choose when antibiotics are truly needed.
www.cidrap.umn.edu/antimicrobia...
New @cidrap.bsky.social article shows dentists still write millions of antibiotic prescriptions annually, many of which may be unnecessary. CP3’s Dr. Katie Suda was consulted on the need for improved stewardship in dental settings to curb overuse and resistance.
www.cidrap.umn.edu/antimicrobia...
🆕study co-authored by CP3’s @timandersonmd.bsky.social finds 9% of US adults 30–59 have ⬆️30-year ASCVD risk despite⬇️10-year risk. Many have uncontrolled risk factors, & expanding statins could benefit ~2.5M more adults. Long-term risk may reshape prevention.
pmc.ncbi.nlm.nih.gov/articles/PMC...
🆕study led by CP3’s @bryantshuey.bsky.social finds employer-mandated switches to high-deductible plans were linked to delays in OUD-related high-acuity care and 37% fewer high-acuity care days, raising concerns about cost-sharing barriers to timely treatment.
journals.lww.com/journaladdic...
The agenda for @cpddorg.bsky.social #cpdd26 is out, and we can't wait to join our colleagues from @brownpublichealth.bsky.social to share lessons learned from implementing #machinelearning driven #overdose prevention interventions!
cpdd.societyconference.com/conf/#sessio...
New @plosone.org study finds long-term opioid therapy is linked to higher risk of infection-related dental outcomes in a national VA cohort, underscoring oral health risks in chronic opioid users. CP3's Dr. Katie Suda is a co-author.
journals.plos.org/plosone/arti...
CP3's @timandersonmd.bsky.social spoke with @statnews.com about the importance of conversations between patient and prescriber when making decisions about statins and other medications.
Read more:
www.statnews.com/2026/02/05/s...
🆕paper co-authored by CP3’s @timandersonmd.bsky.social highlights how longer life expectancy has expanded the number of older adults with CVD risk. Using the Geriatric 5Ms, it reviews new BP & lipid guidelines to support personalized prevention in aging adults.
www.sciencedirect.com/science/arti...
ICYMI: CP3's Dr. Tom Radomski reflects on moving from student to associate director of Pitt's ICRE in Pitt Med magazine. (Bonus cameos of CP3 Director @walidgellad.bsky.social & faculty affiliate Dr. Julie Donohue!)
www.pittmed.pitt.edu/news/institu...
Our latest newsletter is live! Through the holiday break and a huge winter storm, we kept busy!
createsend.com/t/j-DBA41D16...
🆕study by CP3’s @timandersonmd.bsky.social shows that even when discharge summaries and instructions align, older adults misunderstood >50% of cardiometabolic 💊 changes. Concordance doubled understanding but clearer discharge communication needed.
agsjournals.onlinelibrary.wiley.com/doi/10.1111/...
CP3 Director @walidgellad.bsky.social will moderate a panel at the Novel Solutions to Address the Rising Cost of Oncology Drugs conference, hosted by the University of Chicago & Georgetown Law, focused on demand-side strategies to improve cancer drug affordability.
cpt.uchicago.edu/program/
🆕 Study co-authored by CP3’s @jennylociganic.bsky.social used EHR data to build #machinelearning models predicting which patients receive pharmacogenetic testing for #opioid therapy. Results show strong performance and promise for precision pain care.
medinform.jmir.org/2026/1/e81048
🆕study co-authored by CP3’s @walidgellad.bsky.social & Noah Feder finds only ~30% of hospitals fully comply with CMS price transparency rules, with most failing to report negotiated rates. PPS-exempt hospitals showed similar gaps.
www.sciencedirect.com/science/arti...
New @arstechnica.com piece highlights work by CP3’s @timandersonmd.bsky.social showing that #GLP-1 drugs improve heart health, but benefits fade when treatment stops—raising important questions about long-term use, adherence, and chronic disease management.
arstechnica.com/health/2025/...
🆕study co-authored by CP3’s @timandersonmd.bsky.social finds current transitions of care programs are fragmented, harming pt handoffs. Improving outcomes will require addressing social needs, stronger leadership support, & pt-centered care.
shmpublications.onlinelibrary.wiley.com/doi/10.1002/...
New study co-authored by CP3’s Dr. Ted Park finds postoperative opioid and benzodiazepine prescribing often mirrors patients’ pre-surgery use rather than new surgical needs. Understanding these patterns is key to tailoring surgery-specific interventions.
journals.lww.com/journalacs/a...
Our team worked with partners at ACDHS to develop a risk prediction model to determine risk of overdose after a person leaves jail. Time spent in a carceral setting has a huge impact on people's vulnerability.
cp3.pitt.edu/allegheny-co...
We love seeing CP3's Dr. Sarah Belcher & Dr. Luke Berenbrok's work highlighted in Pitt Research's Annual Report! We continue to make impact on healthcare!
Dr. Belcher: www.research.pitt.edu/report/impro...
Dr. Berenbrok: www.research.pitt.edu/report/impro...
We're so happy that @drjuanhc.com is officially part of Pitt and CP3! Our work together will be even stronger with you here, Juan!
14.01.2026 14:12 — 👍 1 🔁 0 💬 0 📌 0
Excited to start the year by planning to share our #riskprediction work at 2 conferences: @upmc.com Digital Health Summit & @cpddorg.bsky.social #cpdd36! At #cpdd26, we'll join colleagues from @brownpublichealth.bsky.social to share lessons learned from our experience doing this work. See you there!
12.01.2026 19:10 — 👍 2 🔁 1 💬 0 📌 0
New study co-authored by CP3’s Dr. Julie Donohue highlights Medicaid’s crucial role in covering seriously ill adults and shows the need for Medicaid programs to focus more on ICU patients before, during, and after hospitalization to improve care and outcomes.
pmc.ncbi.nlm.nih.gov/articles/PMC...
New national study shows alcohol-related hospitalizations stayed stable from 2016–2022, but mortality, length of stay, & costs rose. Findings highlight the need for prevention & earlier AUD treatment to improve outcomes & reduce spending.
@timandersonmd.bsky.social
jamanetwork.com/journals/jam...
Many older adults are stopping their #GLP-1 medications. @nytimes.com spoke with experts, including CP3's @timandersonmd.bsky.social to learn more.
@pittdeptofmed.bsky.social @pittgim.bsky.social
www.nytimes.com/2025/12/21/h...
More than 1 in 10 older adults in Medicare Part D Medication Therapy Management use multiple CNS meds, increasing fall risk, yet only ~1/3 get a comprehensive med review. Better engagement needed to reduce risk.
@timandersonmd.bsky.social
www.jmcp.org/doi/10.18553...
Congrats to Yujin Seo (CMU), working with CP3’s Dr. Katie Suda, on presenting at the IQVIA Institute Research Forum. Her poster shows drug shortages hit older adults hardest, with faster fill declines among Medicare/Medicaid patients and those linked to rural or lower-income prescribers.
19.12.2025 15:32 — 👍 2 🔁 0 💬 0 📌 0
New study co-authored by CP3’s @timandersonmd.bsky.social shows limited lecanemab uptake in the VHA and that nearly 30% of patients had ARIA or stroke within 7 months of starting treatment, highlighting the need for careful long-term safety and effectiveness monitoring.
www.mdpi.com/2077-0383/14...
Welcome to CP3! Juan M. Hincapie-Castillo (@drjuanhc.com) will join Pitt’s School of Pharmacy as Associate Professor (pending) in Jan 2026 & as a CP3 faculty affiliate. A longtime collaborator & 2024 Pharmacoequity panelist, his work focuses on legal epidemiology & evidence-based policymaking.
17.12.2025 18:04 — 👍 4 🔁 0 💬 0 📌 1